ImmunoPrecise Antibodies Reschedules Financial Results and Business Highlights Report

Rescheduling Announcement

ImmunoPrecise Antibodies Ltd. (IPA), a leader in artificial intelligence-driven biotherapeutic research and technology, has announced a change in its reporting schedule. The company will postpone the release of its financial results and recent business highlights for the fourth quarter and fiscal year-end 2024 1

1

.

Reasons for Delay

The primary reason cited for this rescheduling is the need for additional time to complete the company's year-end audit procedures. IPA has stated that this extension is necessary to ensure the accuracy and completeness of their financial reporting 2

2

.

New Reporting Date

ImmunoPrecise Antibodies has set a new date for the release of its financial results and business highlights. The company now plans to issue this report before the market opens on Thursday, August 3, 2023 1

1

. This new schedule allows for the thorough completion of all necessary audit procedures.

Conference Call Details

Following the release of the financial results, IPA has scheduled a conference call and audio webcast for investors and analysts. This call will take place on the same day, August 3, 2023, at 10:30 am Eastern Time. During this call, the company's management will discuss the financial results and provide an update on recent corporate developments 2

2

.

Participation Information

For those interested in participating in the conference call, IPA has provided dial-in details. Participants can access the call using the following information:

• North American toll-free: 1-877-407-3982
• International: 1-201-493-6780
• Conference ID: 13739398 1

  1

Additionally, a live audio webcast of the call will be available on the Events section of the ImmunoPrecise Antibodies website.

Replay Availability

For those unable to attend the live call, IPA will make a replay of the conference call available. The audio replay can be accessed by dialing 1-844-512-2921 in North America or 1-412-317-6671 internationally, using the replay pin number 13739398. This replay will be available for approximately 30 days following the call 2

2

.

About ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies Ltd. is a biotherapeutic research and technology company that leverages artificial intelligence in its operations. The company specializes in the discovery and development of therapeutic antibodies for both humans and animals. With its innovative approach, IPA aims to transform the possibilities of human and animal health 1

1

2

2

.